Chugai Pharmaceutical Co Ltd
F:CUP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elemental Royalty Corp
F:A980
|
CA |
|
Time Finance PLC
F:B5D1
|
UK |
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
C
|
CECONOMY AG
F:CEC
|
DE |
|
S
|
Sellas Life Sciences Group Inc
F:RXK3
|
US |
|
Millicom International Cellular SA
F:M4M1
|
LU |
|
B
|
Biome Grow Inc
SWB:6OTA
|
CA |
|
C
|
Chugai Pharmaceutical Co Ltd
OTC:CHGCY
|
JP |
|
Tofutti Brands Inc
OTC:TOFB
|
US |
|
Lesaka Technologies Inc
NASDAQ:LSAK
|
ZA |
|
M
|
Merry Electronics Co Ltd
TWSE:2439
|
TW |
|
P
|
Park Systems Corp
KOSDAQ:140860
|
KR |
|
Orge Enerji Elektrik Taahhut AS
IST:ORGE.E
|
TR |
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
Illumina Inc
NASDAQ:ILMN
|
US |
|
Investors Title Co
NASDAQ:ITIC
|
US |
|
S
|
Subaru Corp
DUS:FUH
|
JP |
|
Global Dominion Access SA
MAD:DOM
|
ES |
|
Shimano Inc
F:SHM
|
JP |
|
A
|
Alset Ehome International Inc
NASDAQ:AEI
|
US |
|
H
|
Hongkong and Shanghai Hotels Ltd
OTC:HKSHF
|
HK |
|
D
|
Dongkuk Refractories & Steel Co Ltd
KOSDAQ:075970
|
KR |
Economic Moat
Chugai Pharmaceutical has a narrow economic moat
Patent protection prevents rivals from freely copying Chugai’s medicines and the antibody technologies used to develop them. Drugs such as Hemlibra turn that protection into sales and licensing income, while its protected research technologies also support the development of new treatments.
What protects Chugai Pharmaceutical from competitors
Intangible Assets
Chugai holds patents covering its medicines and proprietary antibody engineering technologies, including technology used in Hemlibra for hemophilia A. These rights stop competitors from freely copying protected inventions, allowing Chugai to earn money from selling medicines and licensing its discoveries to other companies.
What could weaken Chugai Pharmaceutical's moat
1 risk to watch
What could happen to the source of the moat and how it would weaken it
